Similar articles for PMID: 21527360

Year	Number of Results
1995	1
1998	2
2001	1
2002	1
2003	2
2004	1
2005	5
2006	13
2007	8
2008	9
2009	7
2010	11
2011	5
2012	4
2013	8
2014	9
2015	4
2016	7
2017	3
2018	2
2019	7
2020	8
2021	12
2022	2
2023	3
2024	0

1

Rationale and design of a trial on the role of bosentan in Fontan patients: improvement of exercise capacity?

Schuuring MJ, Vis JC, Bouma BJ, van Dijk AP, van Melle JP, Pieper PG, Vliegen HW, Sieswerda GT, Mulder BJ. Schuuring MJ, et al. Contemp Clin Trials. 2011 Jul;32(4):586-91. doi: 10.1016/j.cct.2011.04.001. Epub 2011 Apr 17. Contemp Clin Trials. 2011. PMID: 21527360 Clinical Trial.

2

Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study.

Hebert A, Mikkelsen UR, Thilen U, Idorn L, Jensen AS, Nagy E, Hanseus K, Sørensen KE, Søndergaard L. Hebert A, et al. Circulation. 2014 Dec 2;130(23):2021-30. doi: 10.1161/CIRCULATIONAHA.113.008441. Epub 2014 Oct 20. Circulation. 2014. PMID: 25446057 Clinical Trial.

3

Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial.

Schuuring MJ, Vis JC, van Dijk AP, van Melle JP, Vliegen HW, Pieper PG, Sieswerda GT, de Bruin-Bon RH, Mulder BJ, Bouma BJ. Schuuring MJ, et al. Eur J Heart Fail. 2013 Jun;15(6):690-8. doi: 10.1093/eurjhf/hft017. Epub 2013 Jan 29. Eur J Heart Fail. 2013. PMID: 23361871 Free article. Clinical Trial.

4

Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease.

Apostolopoulou SC, Manginas A, Cokkinos DV, Rammos S. Apostolopoulou SC, et al. Heart. 2005 Nov;91(11):1447-52. doi: 10.1136/hrt.2004.051961. Epub 2005 Mar 10. Heart. 2005. PMID: 15761050 Free PMC article. Clinical Trial.

5

Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study.

Apostolopoulou SC, Manginas A, Cokkinos DV, Rammos S. Apostolopoulou SC, et al. Heart. 2007 Mar;93(3):350-4. doi: 10.1136/hrt.2006.100388. Epub 2006 Sep 15. Heart. 2007. PMID: 16980516 Free PMC article. Clinical Trial.

6

Relation of systemic venous return, pulmonary vascular resistance, and diastolic dysfunction to exercise capacity in patients with single ventricle receiving fontan palliation.

Goldstein BH, Connor CE, Gooding L, Rocchini AP. Goldstein BH, et al. Am J Cardiol. 2010 Apr 15;105(8):1169-75. doi: 10.1016/j.amjcard.2009.12.020. Epub 2010 Feb 20. Am J Cardiol. 2010. PMID: 20381672 Clinical Trial.

7

Efficacy of endothelin blockade in adults with Fontan physiology.

Derk G, Houser L, Miner P, Williams R, Moriarty J, Finn P, Alejos J, Aboulhosn J. Derk G, et al. Congenit Heart Dis. 2015 Jan-Feb;10(1):E11-6. doi: 10.1111/chd.12189. Epub 2014 May 30. Congenit Heart Dis. 2015. PMID: 24890846 Clinical Trial.

8

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.

Galiè N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, Chiossi E, Landzberg M; Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Galiè N, et al. Circulation. 2006 Jul 4;114(1):48-54. doi: 10.1161/CIRCULATIONAHA.106.630715. Epub 2006 Jun 26. Circulation. 2006. PMID: 16801459 Clinical Trial.

9

Impact of vitamin C on endothelial function and exercise capacity in patients with a Fontan circulation.

Goldstein BH, Sandelin AM, Golbus JR, Warnke N, Gooding L, King KK, Donohue JE, Yu S, Gurney JG, Goldberg CS, Rocchini AP, Charpie JR. Goldstein BH, et al. Congenit Heart Dis. 2012 May-Jun;7(3):226-34. doi: 10.1111/j.1747-0803.2011.00605.x. Epub 2011 Dec 18. Congenit Heart Dis. 2012. PMID: 22176653 Free article. Clinical Trial.

10

The safety and effects of bosentan in patients with a Fontan circulation.

Bowater SE, Weaver RA, Thorne SA, Clift PF. Bowater SE, et al. Congenit Heart Dis. 2012 May-Jun;7(3):243-9. doi: 10.1111/j.1747-0803.2012.00635.x. Epub 2012 Feb 20. Congenit Heart Dis. 2012. PMID: 22348734 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

116 results

Results by year